Materialise, headquartered in Leuven, Belgium, announced that it has invested in Replasia, a Belgian medtech start-up developing personalised, additively manufactured solutions and anatomical analysis software for hip preservation.

Materialise stated that this investment reflects its belief that personalised treatments can play an important role in improving clinical outcomes and that hip preservation is becoming an increasingly important aspect of orthopaedic care.